Cardiovascular complications in COVID-19

• Published in: The American journal of emergency medicine Vol. 38; no. 7; pp. 1504 - 1507
• Main Authors: Long, Brit, Brady, William J., Koyfman, Alex, Gottlieb, Michael
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2020; Elsevier Limited; W B Saunders
• Subjects: ACE2; Acute coronary syndromes; Acute myocardial infarction; Angiotensin; Angiotensin-converting enzyme 2; Arrhythmias, Cardiac - pathology; Arrhythmias, Cardiac - virology; Betacoronavirus; Cardiovascular; Cardiovascular diseases; Cardiovascular Diseases - pathology; Cardiovascular Diseases - virology; Cardiovascular system; Congestive heart failure; Coronaviridae; Coronavirus Infections - immunology; Coronaviruses; COVID-19; Dysrhythmia; Emergency medical care; Heart attacks; Heart failure; Heart Failure - pathology; Heart Failure - virology; Humans; Infectious disease; Morbidity; Mortality; Myocardial infarction; Myocarditis; Myocarditis - pathology; Myocarditis - virology; Pandemics; Peptidyl-dipeptidase A; Pneumonia, Viral - immunology; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Thromboembolism; Troponin; China; COVID-19; Heart failure; Myocarditis; Infectious disease; Troponin; Dysrhythmia; Cardiovascular; Acute myocardial infarction

The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. This brief report evaluate...